Search is Powered by Google
Medical Devices News

CMS Proposes Medicare Coverage For Artificial Hearts Manufactured By Abiomed, SynCardia

Main Category: Medical Devices
Also Included In: Cardiovascular / Cardiology;  Medicare / Medicaid / SCHIP
Article Date: 06 Feb 2008 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:1 star

1 (1 votes)

Article Opinions: 0 posts

Artificial heart manufacturers Abiomed and SynCardia Systems on Monday announced that CMS has proposed to extend Medicare coverage to the devices for beneficiaries who participate in clinical trials approved by FDA, the AP/Boston Herald reports. The proposal opens a 30-day public comment period, with CMS expected to issue a final Medicare coverage decision by May 1.

The proposal would reverse a policy established in 1986 that denied Medicare coverage for artificial hearts, which only the sickest patients receive. FDA officials on Friday said that "there is now sufficient scientific evidence on the use of artificial hearts to allow coverage" for Medicare beneficiaries enrolled in trials approved by the agency.

Three private health insurers recently announced they would cover AbioCor, an artificial heart manufactured by Abiomed. FDA in September 2006 allowed Abiomed to market AbioCor, which cost about $250,000, to about 4,000 of the sickest patients. No patients to date have received AbioCor. According to Abiomed officials, Medicare coverage for AbioCor might not lead to increased use of the device but might address some related cost concerns. Abiomed Chair, President and CEO Michael Minogue said, "We now have a validation from the FDA that this technology works, and we have some proposed validation" from CMS.

FDA in October 2004 approved the CardioWest temporary Total Artificial Heart, manufactured by SynCardia. More than 700 terminally ill heart failure patients to date have received CardioWest as they waited for transplants.

Gregory Simpson, an analyst with Stifel Nicolaus who tracks Abiomed, on Monday in a research note said that most investors would consider Medicare coverage for AbioCor a "nonevent" (AP/Boston Herald, 2/4).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Keeping Limber on the Job
Keeping Limber on the Job

Find out how to stretch your muscles right at your desk to stay limber on the job.

more videos are available in our health videos section.